Press releases
- Photocure Announces Mobile BLC Tower Initiative to Expand Access to Cysview in the U.S.
- Photocure ASA - Annual general meeting held
- Photocure ASA: Results for the first quarter of 2024
- Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China
- Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024
- Photocure ASA - Notice of the Annual General Meeting 23 May 2024
- Photocure ASA: Annual Report 2023
- European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care
More ▼
Key statistics
As of last trade, Photocure ASA (PHS:DUS) traded at 5.12, 13.53% above the 52 week low of 4.51 set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 5.12 |
---|---|
High | 5.12 |
Low | 5.12 |
Bid | 5.09 |
Offer | 5.15 |
Previous close | 5.23 |
Average volume | 0.00 |
---|---|
Shares outstanding | 27.12m |
Free float | 26.68m |
P/E (TTM) | 332.86 |
Market cap | 1.58bn NOK |
EPS (TTM) | 0.1755 NOK |
Data delayed at least 15 minutes, as of Jul 05 2024 07:12 BST.
More ▼